How much revenue does Genesis Ibrc India make?

Genesis Ibrc India reported 0 INR in revenue for fiscal year 2025. In Q3 2026 revenue was 0 INR.

What companies are similar to Genesis Ibrc India?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Albert David Limited (ALBERTDAVD.NS), Trident Lifeline Limited (TLL.BO), Jenburkt Pharmaceuticals Limited (JENBURPH.BO), Ambalal Sarabhai Enterprises Limited (AMBALALSA.BO).

Genesis Ibrc India Ltd (GENESIS.BO) Stock

About Genesis Ibrc India Ltd

CCME Global Limited does not have significant operations. The company was previously engaged in the manufacture and marketing of pro-biotic products for aquaculture, agriculture, poultry, and animal husbandry markets in India. The company was formerly known as Genesis IBRC India Limited and changed its name to CCME Global Limited in March 2026. CCME Global Limited was incorporated in 1992 and is b...

At a glance

Genesis Ibrc India reported revenue of 0 INR for fiscal year 2025, and net income of 35.05 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 0 INR.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.